SACHEM HILL LLC — 13F Portfolio

Schoolcraft Capital LLC is a New York-based hedge fund that files quarterly 13F reports with the U.S. Securities and Exchange Commission under CIK #0001994333. Established as a fundamentally driven investment management firm, Schoolcraft Capital operates from the heart of the global financial industry's epicenter, positioning itself within the dense ecosystem of alternative asset managers, prime brokers, and institutional service providers that characterize the New York hedge fund landscape. The firm is structured as a limited liability company, a standard organizational form for hedge fund management entities that provides operational flexibility, liability protection for members, and pass-through tax treatment. Under the leadership of David Zola, who serves as Managing Partner and Chief Investment Officer, Schoolcraft Capital was founded with a mandate to generate risk-adjusted returns through rigorous fundamental analysis and disciplined portfolio construction. Zola's investment career, developed across institutional trading and portfolio management roles, informs the firm's analytically intensive approach to public equity markets. As a relatively recent entrant to the 13F filing universe, Schoolcraft Capital represents an emerging generation of hedge fund managers that have launched in a market environment characterized by elevated volatility, rapid technological disruption, and evolving factor dynamics. The firm's SEC filings provide the primary public window into its U.S. equity positioning, and the platform's 13F history tools enable users to track the full evolution of disclosed holdings from inception through each subsequent quarterly filing.

Schoolcraft Capital LLC employs a fundamentally driven long/short equity strategy that combines deep bottom-up research with a macro-aware overlay. The firm's investment philosophy centers on identifying mispriced securities where the market's consensus expectations diverge meaningfully from the firm's proprietary assessment of intrinsic value, creating opportunities on both the long and short sides of the portfolio. On the long side, the strategy targets companies with durable competitive advantages, improving unit economics, and catalysts for earnings re-rating. On the short side, the firm seeks out businesses facing structural deterioration, competitive displacement, or accounting and governance concerns that the market has not fully discounted. This dual-mandate approach is designed to generate alpha through security selection while managing net market exposure to deliver more consistent risk-adjusted outcomes across market cycles. The firm's 13F Portfolio Composition reveals a portfolio with notable concentrations in the technology and healthcare sectors, two areas where information asymmetries and analytical complexity create fertile ground for fundamental stock-pickers. Within technology, the firm appears to focus on companies benefiting from secular growth themes such as cloud computing, artificial intelligence infrastructure, and digital transformation. Healthcare exposure tends to emphasize companies with differentiated pipelines, innovative therapeutic platforms, or undervalued asset bases relative to the market's risk-adjusted probability assessment of clinical and commercial outcomes. Position sizing reflects a conviction-weighted methodology where the firm's highest-confidence ideas receive disproportionate capital allocation. This approach generates a portfolio that is more concentrated than diversified long-only managers but calibrated to balance conviction with risk management. The Sector Allocation History across quarterly filings provides insight into whether the firm maintains consistent sector exposures or dynamically rotates its emphasis based on evolving opportunity sets and shifting risk-reward dynamics. Turnover patterns suggest a moderate-to-high level of portfolio activity, consistent with a manager that actively manages positions around catalysts, earnings cycles, and evolving fundamental theses. This is not a buy-and-hold strategy — Schoolcraft Capital appears to treat portfolio management as a continuous optimization process, adjusting position sizes and portfolio composition as new information is incorporated into the firm's analytical framework. The platform's backtesting service enables users to reconstruct the capital trajectory implied by these quarterly repositioning decisions.

Schoolcraft Capital LLC presents a compelling analytical profile as a New York-based, fundamentally driven long/short equity hedge fund with concentrated positioning across the technology and healthcare sectors. Filing under CIK #0001994333, the firm's quarterly 13F disclosures provide a systematic — though necessarily partial — record of its U.S. equity positioning, enabling rigorous analysis of its long book composition and evolution over time. Key analytical characteristics include: a conviction-weighted portfolio construction approach that generates return profiles highly sensitive to individual position outcomes; persistent sector tilts toward technology and healthcare that create identifiable factor exposures; and a relatively nascent filing history that limits the depth of historical analysis but offers the opportunity to track the firm's development from its earliest public filings. The Annualized Return (CAGR) computed from disclosed long positions provides a useful but incomplete measure of compounding behavior, as it does not capture the contribution of short positions, hedging overlays, or non-equity instruments that form part of the total fund strategy. Analysts should treat the 13F-derived return series as a lens into the long book's contribution rather than a comprehensive measure of fund-level performance. Areas of genuine analytical interest include the evolution of the firm's sector concentration as the portfolio matures (whether it broadens or deepens its technology and healthcare focus), the consistency of position-level conviction as measured by holding period duration and sizing stability, and the relationship between portfolio repositioning and observable market or company-specific catalysts. The firm's emerging track record creates a particularly interesting analytical challenge: how does Schoolcraft Capital's concentrated, fundamentally driven approach navigate the transition between different market regimes — specifically, does the portfolio demonstrate adaptive capacity when correlations spike and sector leadership rotates abruptly, or does its conviction-based framework maintain exposure through regime transitions, relying on the quality of its fundamental research to generate alpha regardless of the prevailing macro backdrop?

The risk architecture of Schoolcraft Capital LLC is shaped by its long/short equity mandate, concentrated positioning, and sector-specific exposures. Several dimensions of risk are particularly relevant for allocators and analysts evaluating this manager. Net exposure management is a defining element of the firm's risk profile. Unlike long-only managers whose market exposure is structurally fixed near 100%, long/short funds like Schoolcraft Capital can modulate their net and gross exposure to reflect the prevailing opportunity set and risk environment. The 13F filings capture only the long equity book (and put/call positions), meaning the short side of the portfolio — a critical component of the risk management framework — is not fully visible in public disclosures. Analysts should recognize that the disclosed long positions represent only a partial view of the firm's total risk posture. Concentration risk is a significant consideration. The Top 10 Holdings Concentration metric is particularly informative for this manager, as a conviction-weighted portfolio construction approach means the top positions likely represent a substantial share of total long exposure. While concentration can amplify returns during favorable periods, it also increases vulnerability to adverse idiosyncratic events affecting individual holdings. Sector-specific risk is elevated given the firm's technology and healthcare emphasis. Technology holdings carry exposure to interest rate sensitivity, regulatory scrutiny, and competitive disruption cycles. Healthcare positions — particularly those with binary clinical or regulatory catalysts — can experience severe single-day price dislocations that concentrated portfolios absorb more acutely. The combination of these two sectors creates a portfolio with above-average sensitivity to innovation cycles, regulatory policy shifts, and growth-to-value factor rotations. The Max Drawdown Depth observable through historical replication of the firm's quarterly filings quantifies the peak-to-trough capital erosion experienced during adverse periods. For a concentrated long/short manager, drawdown characteristics are often distinct from broad market corrections — they may be driven by idiosyncratic position-level events as much as systematic market declines. The Volatility Profile derived from filing-to-filing changes further illuminates the risk cadence and provides a baseline for evaluating whether the firm's return dispersion is consistent with its stated mandate. Liquidity risk is moderated by the firm's apparent focus on mid-cap and large-cap equities that typically offer reasonable market depth. However, concentrated positions in individual names may still face execution constraints during periods of market stress or if the firm needs to rapidly adjust exposure. As a newer fund, the firm's track record through complete market cycles remains limited. The absence of a multi-cycle performance history introduces uncertainty about how the strategy behaves during extended bear markets, credit dislocations, or prolonged low-volatility environments that can compress long/short spreads.